New research agreement initiated with the University of Manchester

SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on skin health, announces that it has initiated a research programme with the University of Manchester (“the University”) to investigate and develop microbiome formulations that support natural anti-inflammatory response to a range of environmental challenges. Expanding the collaboration with the University was one of the areas of investment laid out by the Company when it raised funds via placing and open offer in October 2020.

» Download full article

Previous ArticleNext Article